New clinical data repository built on
SAS® Viya® offers an open, cloud-native, and
scalable analytics platform to boost productivity and accelerate
innovation
CARY,
N.C., June 18, 2024 /PRNewswire/ -- Data offers
limitless opportunities to life sciences and health care
organizations. It empowers clinical researchers to analyze and
uncover trends that can lead to groundbreaking treatments, and it
is the foundation to unlocking health care insights more
quickly.
SAS Clinical Acceleration Repository, a secure, cloud-native
data repository with robust audit and administration capabilities,
is now available to help drive innovation for life sciences and
health organizations. The analytics platform manages clinical
research data, integrates with various data sources, improves
clinical trial development and accelerates the path to regulatory
submission.
Streamlining and securing clinical data for
innovation
Establishing a secure, advanced data repository
to manage clinical data and support clinical trial development from
various sources, transforming and preparing it for statistical
analytics, and packaging it for regulatory submission is a common
challenge for many global companies. Additionally, data management
and governance challenges can delay clinical research. SAS Clinical
Acceleration Repository provides a modular, open, cloud-native
content repository for managing, reporting, sharing and reviewing
data.
The unique benefits of SAS Clinical Acceleration Repository
include:
- Access to curated research information and health data through
a single system of record via an easy-to-use, modern user interface
with intuitive dashboards.
- A production-ready data repository that enables easier and
faster data validation. The solution supports groups and
permissions, roles and privileges, electronic signatures, version
control, search, and an audit trail, while also enabling continuous
monitoring and data preservation to support security, and
regulatory and data standards compliance.
- A multi-lingual, open environment to support use of third-party
programming languages and tools and data integration from many
locations and sources, such as electronic data capture systems,
in-house clinical data management systems, labs and contract
research organizations.
- Access to SAS Viya enabled solutions and technology – proven to
be 30 times faster than commercial and open-source alternatives –
to improve efficiency and speed the path to submission.
"SAS Clinical Acceleration Repository enables researchers and
data scientists to better manage their clinical data and empowers
organizations to make informed business decisions," said
Gail Stephens, Vice President of
Health Care and Life Sciences at SAS. "Accelerating and improving
the clinical development process helps bring therapies to market
sooner and strengthens the bottom line for life sciences and health
organizations."
SAS will unveil the new solution at the Drug Information
Association 2024 Global Annual Meeting (DIA 2024) this week in
San Diego, CA.
Generating synthetic data to bridge gaps in real-world
data
Synthetic data is increasingly being used in the health
care and life sciences industries to train and test AI systems in
place of or in addition to real-world data. To further support the
data and AI needs for health and clinical research, SAS has
introduced SAS Data Maker (currently in private preview).
The powerful synthetic data generation capabilities of SAS Data
Maker address data privacy and scarcity challenges by generating
synthetic tabular data that statistically represents original
training data without compromising sensitive patient health
information. This enables health care and life sciences companies
to innovate faster by combining trusted data augmentation and
generation algorithms in one seamless tool.
"SAS Data Maker uses SAS' cutting-edge, reliable AI models to
create statistically accurate data points that truly augment
existing data and can capture countless different scenarios,
helping organizations better forecast outcomes so they can
anticipate their businesses' changing needs," said Shadi Shahin, Vice President of Product Strategy
at SAS. "This is particularly valuable in instances where specific
real-world data is hard to come by or when there's a need to detect
rare case scenarios in highly regulated areas like health care and
life sciences."
AstraZeneca, a global biopharmaceutical company, intends to use
SAS Data Maker on the Snowflake Marketplace to empower its data
scientists through the use of synthetic data to further improve
decision making.
"Synthetic data can enhance our ability to make informed
decisions from critical data, and thus has the real potential to
help accelerate drug discovery and development, ultimately
benefiting patients around the world," noted Brian Dummann, Chief Data Officer at
AstraZeneca. "We look forward to leveraging SAS Data Maker and
streamlining how data scientists can access synthetic data for
their initiatives."
Employing AI to boost industry solutions
The new
health care and life sciences products are outcomes of SAS'
commitment of $1 billion to
AI-powered industry solutions over three years. As outlined in the
May 2023 announcement, the investment
in AI builds on SAS' decades-long focus on providing tailored
solutions to industry challenges in banking, government, insurance,
health care, and more.
Learn more about how SAS delivers the most productive AI
platform to transform data into life-changing insights and
accelerate breakthroughs in life sciences and health care here.
About SAS
SAS is a global leader in data and AI. With
SAS software and industry-specific solutions, organizations
transform data into trusted decisions. SAS gives you THE POWER TO
KNOW®.
SAS and all other SAS Institute Inc. product or service names
are registered trademarks or trademarks of SAS Institute Inc. in
the USA and other countries. ®
indicates USA registration. Other
brand and product names are trademarks of their respective
companies. Copyright © 2024 SAS Institute Inc. All rights
reserved.
Editorial Contact:
Jennifer James
jennifer.james@sas.com
919-531-0858
sas.com/news
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sas-expands-portfolio-of-data-and-ai-solutions-for-life-sciences-and-health-care-302175906.html
SOURCE SAS